×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Did you mean:
Biocryst
Pharma
Director Steven Galson Acquires 21,940 Shares of BioCryst Pharmaceuticals Inc (BCRX)
Yahoo Finance
On May 13, 2024, Steven Galson, a Director at BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 21940 shares of the company,...
6 days ago
BioCryst Pharmaceuticals (BCRX) Q1 2024 Earnings Call Transcript
The Motley Fool
BioCryst Pharmaceuticals (BCRX -2.94%) Q1 2024 Earnings Call May 06, 2024, 8:30 a.m. ET. Contents: Prepared Remarks; Questions and Answers...
2 weeks ago
January 2026 Options Now Available For BioCryst Pharmaceuticals (BCRX)
Nasdaq
Investors in BioCryst Pharmaceuticals Inc (Symbol: BCRX) saw new options become available today, for the January 2026 expiration.
2 weeks ago
Insider Buying: CFO Anthony Doyle Acquires Shares of BioCryst Pharmaceuticals Inc (BCRX)
Yahoo Finance
Anthony Doyle, Chief Financial Officer of BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 36300 shares of the company on May 14, 2024.
6 days ago
Why Is BioCryst Stock Trading Higher On Monday? - BioCryst Pharma (NASDAQ:BCRX)
Benzinga
Monday, BioCryst Pharmaceuticals Inc. BCRX-0.77%. + Free Alerts. reported a first-quarter earnings loss of $(0.17) per share versus the...
2 weeks ago
Insufficient Growth At BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Hampers Share Price
Simply Wall Street
BioCryst Pharmaceuticals, Inc.'s ( NASDAQ:BCRX ) price-to-sales (or "P/S") ratio of 2.6x might make it look like a...
3 weeks ago
Why BioCryst Pharmaceuticals Vaulted Nearly 20% Higher on Monday
The Motley Fool
A better-than-expected first quarter and a goal of profitability and positive cash flow by the end of 2025 brought on a bit of a rally.
2 weeks ago
Insider Buying: Charles Gayer Acquires 30,000 Shares of BioCryst Pharmaceuticals Inc (BCRX)
Yahoo Finance
Charles Gayer, Chief Commercial Officer of BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 30000 shares of the company on May 13,...
6 days ago
BioCryst Pharmaceuticals (BCRX) Q4 2023 Earnings Call Transcript
The Motley Fool
It was great to see such a strong Q4 and full year 2023 for ORLADEYO. Not just the revenue performance, but the continued underlying strength in...
2 months ago
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q1 2024 Earnings Call Transcript
Yahoo Finance
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q1 2024 Earnings Call Transcript May 6, 2024 BioCryst Pharmaceuticals, Inc. misses on earnings...
2 weeks ago